GSTT1 and M1 polymorphisms in Hürthle thyroid cancer patients

Cancer Letters

Volumn 240, Issue 1, 2006, Pages 76-82

  Stankov, Karmen ^a   Landi, Stefano ^b,c   Gioia Patricola, Lydie ^c   Bonora, Elena ^a   Volante, Marco ^d   Papotti, Mauro ^d,e   Romeo, Giovanni ^f  

^a Dipartimento di Medicina Interna   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF TURIN   (Italy)

^e SAN LUIGI GONZAGA HOSPITAL   (Italy)

^f NONE

Author keywords

Genetic susceptibility; GSTM1; GSTT1; H rthle cell tumors; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; THYROID CANCER; THYROID PARAFOLLICULAR CELL;

ADENOMA, OXYPHILIC; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; THYROID NEOPLASMS;

EID: 33745961685     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.08.017     Document Type: Article

References (37)

1. Franceschi S., Boyle P., Maisonneuve P., La Vecchia C., Burt A.D., Kerr D.J., et al. The epidemiology of thyroid carcinoma. Crit. Rev. Oncog. 4 (1993) 25-52
2. Franceschi S., and Dal Maso L. Hormonal imbalances and thyroid cancers in humans. IARC Sci. Publ. 147 (1999) 33-43
3. Henderson B.E., Ross R.K., and Pike M.C. Toward the primary prevention of cancer. Science 254 (1991) 1131-1138
4. Belfiore A., La Rosa G.L., La Porta G.A., Giuffrida D., Milazzo G., Lupo L., et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am. J. Med. 93 (1992) 363-369
5. Levi F., Franceschi S., Gulie C., Negri E., and La Vecchia C. Female thyroid cancer: the role of reproductive and hormonal factors in Switzerland. Oncology 50 (1993) 309-315
6. Canzian F., Amati P., Harach H.R., Kraimps J.L., Lesueur F., Barbier J., et al. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am. J. Hum. Genet 63 (1998) 1743-1748
7. McKay J.D., Lesueur F., Jonard L., Pastore A., Williamson J., Hoffman L., et al. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am. J. Hum. Genet. 69 (2001) 440-446
8. Tallini G. Oncocytic tumors. Virchows Arch. 433 (1998) 5-12
9. Máximo V., and Sobrinho-Simões M. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch. 437 (2000) 107-115
10. Stankov K., and Romeo G. Oxyphilic carcinoma of the thyroid. Arch. Oncol. 11 (2003) 13-21
11. Hoos A., Stojadinovic A., Singh B., Dudas M.E., Leung D.H., Shaha A.R., et al. Clinical significance of molecular expression profiles of Hurthle cell tumors of the thyroid gland analyzed via tissue microarrays. Am. J. Pathol. 160 (2002) 175-183
12. Máximo V., Sores P., Rocha A.S., and Sobrinho-Simões M. The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change. Ultrastruct. Pathol. 22 (1998) 271-273
13. Müller-Höcker J., Jacob U., and Seibel P. Hashimoto thyroiditis is associated with defects of cytochrome-c oxidase in oxyphil Askanazy cells and with the common deletion (4,977) of mitochondrial DNA. Ultrastruct. Pathol. 22 (1998) 91-100
14. Lenaz G. Role of mitochondria in oxidative stress and aging. Biochim. Biophys. Acta 1336 (1998) 53-67
15. Lenaz G., D'Aurelio M., Merlo Pich M., Genova M.L., Ventura B., Bovina C., et al. Mitochondrial bioenergetics in aging. Biochim. Biophys. Acta 1459 (2000) 397-404
16. Volante M., Papotti M., Gugliotta P., Migheli A., and Bussolati G. Extensive DNA fragmentation in oxyphilic cell lesions of the thyroid. J. Histochem. Cytochem. 49 (2001) 1003-1011
17. Lee H.C., Yin P.H., Lu C.Y., Chi C.W., and Wei Y.H. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem. J. 348 (2000) 425-432
18. Oberley T.D. Oxidative damage and cancer. Am. J. Pathol. 160 (2002) 403-408
19. K. Stankov, A. Biondi, M. D'Aurelio, G. Gasparre, G. Romeo, G. Lenaz, Mitochondrial activities of cell line derived from thyroid Hürthle cell tumors, Thyroid, inpress.
20. Stankov K., and Kovacevic Z. Oxidative stress and glutathione-associated antioxidative systems in malignant cells. Arch. Oncol. 6 (1998) 109-113
21. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer. Res. 54 (1994) 4313-4321
22. Strange R.C., Spiteri M.A., Ramachandran S., and Fryer A.A. Glutathione-S-transferase family of enzymes. Mutat. Res. 482 (2001) 21-26
23. Strange R.C., Jones P.W., and Fryer A.A. Glutathione S-transferase: genetics and role in toxicology. Toxicol. Lett. 112-113 (2000) 357-363
24. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat. Res. 463 (2000) 247-283
25. Raza H., Robin M.A., Fang J.K., and Avadhani N.G. Multiple isoforms of mitochondrial glutathione S-transferases and their differential induction under oxidative stress. Biochem. J. 366 (2002) 45-55
26. Hengstler J.G., Arand M., Herrero M.E., and Oesch F. Polymorphisms of N-acetyltransferases, glutathione s-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Rec. Res. Cancer Res. 154 (1998) 47-85
27. Hernández A., Céspedes W., Xamena N., Surrallés J., Creus A., Galofré P., et al. Glutathione S-transferase polymorphisms in thyroid cancer patients. Cancer Lett. 190 (2003) 37-44
28. Morari C.E., Leite J.L.P., Granja F., da Assumpção L.V., and Ward L.S. The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1485-1488
29. Gaspar J., Rodrigues S., Monteiro Gil O., Manita I., Cruz Ferreira E., Limbert E., et al. Combined effects of glutathione S-transferase polymorphisms and thyroid cancer risk. Cancer Genet. Cytogenet. 151 (2004) 60-67
30. Hayes J.D., and Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61 (2000) 154-166
31. Hayes J.D., and Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30 (1995) 445-600
32. Tumors of endocrine organs. In: De Lellis R.A., Lloyd R.V., Heitz P.U., and Eng C. (Eds). Pathology and Genetics. WHO Classification of Tumors (2004), IARC press, Lyon
33. Rosai J., Carcangiu M.L., and De Lellis R.A. Tumors of the thyroid gland. Atlas of tumor pathology, 3rd series, fascicle 5 (1992), AFIP, Washington p. 1-343
34. Gemignani F., Landi S., Vivant F., Zienolddiny S., Brennan P., Canzian F., et al. A catalogue of polymorphisms related to xenobiotic metabolism and cancer susceptibility. Pharmacogenetics 12 (2002) 459-463
35. Chiappetta G., Toti P., Cetta F., Giuliano A., Pentimalli F., Amendola I., et al. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J. Clin. Endocrinol. Metab. 87 (2002) 364-369
36. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes and GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarker Prev. 6 (1997) 733-743
37. Sweeeny C., Farrow D.C., Schwartz S.M., Eaton D.L., Checkoway H., Vaughan T.L., et al. Glutathione S-transferase M1, T1 and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Cancer Epidemiol. Biomarker Prev. 9 (2000) 449-454